Concepts of Genomics in Kidney Transplantation
- PMID: 29123971
- PMCID: PMC5673265
- DOI: 10.1007/s40472-017-0153-x
Concepts of Genomics in Kidney Transplantation
Abstract
Purpose of review: Identification of genetic variants to aid in individualized treatment of solid organ allograft recipients would improve graft survival. We will review the current state of knowledge for associations of variants with transplant outcomes.
Recent findings: Many studies have yet to exhibit robust and reproducible results, however, pharmacogenomic studies focusing on cytochrome P450 (CYP) enzymes, transporters and HLA variants have shown strong associations with outcomes and have relevance towards drugs used in transplant. Genome wide association study data for the immunosuppressant tacrolimus have identified multiple variants in the CYP3A5 gene associated with trough concentrations. Additionally, APOL1 variants had been shown to confer risk to the development of end stage renal disease in African Americans.
Summary: The field is rapidly evolving and new technology such as next generation sequencing, along with larger cohorts, will soon be commonly applied in transplantation to understand genetic association with outcomes and personalized medicine.
Keywords: APOL1; Kidney transplant; genome wide association studies; genomics; pharmacogenomics; sequencing.
Similar articles
-
The Pharmacogenetics of Tacrolimus in Corticosteroid-Sparse Pediatric and Adult Kidney Transplant Recipients.Drugs R D. 2017 Jun;17(2):279-286. doi: 10.1007/s40268-017-0177-9. Drugs R D. 2017. PMID: 28229376 Free PMC article.
-
CYP3A5 polymorphisms and their effects on tacrolimus exposure in an ethnically diverse South African renal transplant population.S Afr Med J. 2020 Jan 29;110(2):159-166. doi: 10.7196/SAMJ.2020.v110i2.13969. S Afr Med J. 2020. PMID: 32657689
-
Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part II.Clin Pharmacokinet. 2010 Apr;49(4):207-21. doi: 10.2165/11317550-000000000-00000. Clin Pharmacokinet. 2010. PMID: 20214406 Review.
-
Switching Immunosuppression From Cyclosporine to Tacrolimus in Kidney Transplant Recipients Based on CYP3A5 Genotyping.Ther Drug Monit. 2019 Feb;41(1):97-101. doi: 10.1097/FTD.0000000000000579. Ther Drug Monit. 2019. PMID: 30520827
-
The role of pharmacogenetics in the disposition of and response to tacrolimus in solid organ transplantation.Clin Pharmacokinet. 2014 Feb;53(2):123-39. doi: 10.1007/s40262-013-0120-3. Clin Pharmacokinet. 2014. PMID: 24249597 Review.
Cited by
-
Genetic Variants Associated With Immunosuppressant Pharmacokinetics and Adverse Effects in the DeKAF Genomics Genome-wide Association Studies.Transplantation. 2019 Jun;103(6):1131-1139. doi: 10.1097/TP.0000000000002625. Transplantation. 2019. PMID: 30801552 Free PMC article.
-
Elucidating the nexus between onco-immunology and kidney transplantation: An insight from precision medicine perspective.Heliyon. 2024 Jun 26;10(13):e33751. doi: 10.1016/j.heliyon.2024.e33751. eCollection 2024 Jul 15. Heliyon. 2024. PMID: 39040404 Free PMC article. Review.
-
Molecular Markers of Kidney Transplantation Outcome: Current Omics Tools and Future Developments.Int J Mol Sci. 2022 Jun 5;23(11):6318. doi: 10.3390/ijms23116318. Int J Mol Sci. 2022. PMID: 35682996 Free PMC article. Review.
References
-
- Sheldon S, Hasleton PS, Yonan NA, Rhaman AN, Deiraniya AK, Campbell CS, et al. Rejection in heart transplantation strongly correlates with HLA-DR antigen mismatch. Transplantation. 1994;58:719–22. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous